Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q1 2026 | ~2026-03-31 | $0.6300 |
| Q4 2025 | ~2025-12-30 | $0.6300 |
| Q3 2025 | ~2025-09-30 | $0.5900 |
| Q2 2025 | ~2025-06-30 | $0.5900 |
| Q1 2025 | ~2025-03-31 | $0.5900 |
| Q4 2024 | ~2024-12-30 | $0.5900 |
| Q3 2024 | ~2024-09-30 | $0.5500 |
| Q2 2024 | ~2024-06-30 | $0.5500 |
| Q1 2024 | ~2024-03-31 | $0.5500 |
| Q3 2023 | ~2023-09-30 | $0.5100 |
| Q1 2020 | ~2020-03-31 | $0.3600 |
| Q1 2019 | ~2019-03-31 | $0.3200 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Abbott Laboratories is a diversified global healthcare company that develops, manufactures, and distributes a broad range of pharmaceuticals, diagnostic products, nutritional… products, and medical devices. The company operates through four main segments: Established Pharmaceutical Products (including key emerging market medicines), Nutritional Products (pediatric and adult nutritionals), Diagnostic Products (including core laboratory, molecular, point-of-care, and rapid diagnostics), and Medical Devices (including rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care solutions). Abbott's products and services reach approximately 2 billion people globally, with operations in more than 160 countries. The company focuses on innovation for access and affordability, transforming care for chronic diseases and infectious diseases, and advancing health access through partnerships with stakeholders to improve health outcomes.
- Name
- Abbott Laboratories
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert B. Ford · Chairman of the Board and Chief Executive Officer
- Employees
- —
- IPO Date
- 2018-05-01
- Phone
- 2246676100
- Address
- 100 Abbott Park Road, Abbott Park, IL 60064-6400
- Website
- http://www.abbott.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Carla Kriwet | Executive Vice President, Chief Sustainability Officer | — |
| Anil Sood | Executive Vice President, Chief Medical Officer | — |
| Daniel J. Surdell | Executive Vice President, General Counsel and Corporate Secretary | — |
| Jaime Contreras | Executive Vice President, Chief Financial Officer | — |
| Robert B. Ford | Chairman of the Board and Chief Executive Officer | — |
Latest News
- 2026-04-26
- 2026-04-25
- 2026-04-24
-
2026-04-24
Abbott Laboratories: Buying A Healthcare Giant On Sale seekingalpha.com
- 2026-04-24
- 2026-04-24
- 2026-04-21
- 2026-04-21